跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tobidina - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tobidina
Approved
STANDARD
Tobidina
Indiana Ophthalmics
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a2476c3ffa6e2af3
Company
Indiana Ophthalmics
Type
Standard
Approval Details
Approval Id
a2476c3ffa6e2af3
Drug Approval Philippines Name
Tobidina
Product Name
Tobidina
Registration Number
DRP-13479
Brand Name
Tobidina
Generic Name
Tobramycin (as Sulfate)
Dosage Form
Ophthalmic Ointment
Dosage Strength
3 mg/g (0.3% w/w)
Manufacturer
Indiana Ophthalmics
Importer
Aglobal Care Inc.
Distributor
Aglobal Care Inc.
Issuance Date
27 February 2023
Expiry Date
27 February 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a2476c3ffa6e2af3
Type
Standard
Back to Philippines FDA Approvals